Hyaluronan Metabolism in Urologic Cancers
Advanced Biology · 2023
DOI: 10.1002/adbi.202300168 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Biology, 2023. Verfasst von William Donelan und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Florida, Gainesville, FL, 32611, USA. Hauptthemen laut MEDLINE: Hyaluronic Acid, Urologic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UF Health Cancer Center, American Cancer Society Institutional Research Grant, James and Ester King Biomedical Research Program, Florida Health Department, 1923 Fund.
Abstract (Originalsprache)
Hyaluronan (HA) is one of the major components of the extracellular matrix in tumor tissue. Recent reports have made it clear that the balance of HA synthesis and degradation is critical for tumor progression. HA is synthesized on the cytoplasmic surface of the plasma membrane by hyaluronan synthases (HAS) and extruded into the extracellular space. Excessive HA production in cancer is associated with enhanced HA degradation in the tumor microenvironment, leading to the accumulation of HA fragments with small molecular weight. These perturbations in both HA synthesis and degradation may play important roles in tumor progression. Recently, it has become increasingly clear that small HA fragments can induce a variety of biological events, such as angiogenesis, cancer‐promoting inflammation, and tumor‐associated immune suppression. Progression of urologic malignancies, particularly of prostate and bladder cancers, as well as of certain types of kidney cancer show markedly perturbed metabolism of tumor‐associated HA. This review highlights the recent research findings regarding HA metabolism in tumor microenvironments with a special focus on urologic cancers. It also will discuss the potential implications of these findings for the development of novel therapeutic interventions for the treatment of prostate, bladder, and kidney cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Florida, Gainesville, FL, 32611, USA.
- UCLA Medical Center, University of California Los Angeles, Los Angeles, CA, 90095, USA.
ORCID-Profile: Sergei Kusmartsev
Förderung
- UF Health Cancer Center, American Cancer Society Institutional Research Grant
- James and Ester King Biomedical Research Program, Florida Health Department
- 1923 Fund
Zitieren
APA
Donelan, W., Brisbane, W., O'Malley, P., Crispen, P., & Kusmartsev, S. (2023). Hyaluronan Metabolism in Urologic Cancers. Advanced Biology. https://doi.org/10.1002/adbi.202300168
Vancouver
Donelan W, Brisbane W, O'Malley P, Crispen P, Kusmartsev S. Hyaluronan Metabolism in Urologic Cancers. Advanced Biology. 2023. doi:10.1002/adbi.202300168
BibTeX
@article{Donelan2023,
author = {Donelan, William and Brisbane, Wayne and O'Malley, Padraic and Crispen, Paul and Kusmartsev, Sergei},
title = {Hyaluronan Metabolism in Urologic Cancers},
journal = {Advanced Biology},
year = {2023},
doi = {10.1002/adbi.202300168}
}
EUVIMED